Global In - Vitro ADME Services Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global In - Vitro ADME Services Market Insights, Forecast to 2034
In-vitro ADME (Absorption, Distribution, Metabolism, and Excretion) services are a set of techniques used in drug development to assess the pharmacokinetic properties of a compound before it is tested in animals or humans. These services involve the use of in-vitro assays to measure how a compound is absorbed, distributed, metabolized, and eliminated by the body. In-vitro ADME services can provide critical information about a compound's potential efficacy and safety profile, and can help identify potential issues early in the drug development process.
Market Analysis and InsightsGlobal In - Vitro ADME Services Market
Global In - Vitro ADME Services market is expected to reach to US$ 952 million in 2023, with a positive growth of %, compared with US$ 870.2 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, In - Vitro ADME Services industry is evaluated to reach US$ 1543.7 million in 2033. The CAGR will be 8.4% during 2023 to 2033.
Global In - Vitro ADME Services companies include Charles River, Labcorp, Envigo, Curia and Evotec. Global top 3 companies hold a share over 32%. North America is the largest market, with a share about 47%, followed by Europe and Asia-Pacific. In terms of product type, Small Molecules is the largest segment, with a share about 80%. In terms of end user, the largest user is Biopharmaceutical Companies, with a share about 80%, followed by Government and Academic Institutes.
Report Covers
This report presents an overview of global In - Vitro ADME Services market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global In - Vitro ADME Services market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, End User and Regions Listed in the Report
Charles River
Labcorp
Envigo
Curia
Evotec
Bioduro-Sundia
Lonza
WuXi AppTec
IQVIA
Tecan Group
Pharmaron
Shanghai Medicilon
ChemPartner
Joinn Laboratories
RTI International
Eurofins Scientific
Aragen Life Sciences
Sai Life Sciences
Segment by Type
Small Molecules
Biologics
Segment by End User
Biopharmaceutical Companies
Government and Academic Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and end user introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by end user from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and end user from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and end user from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and end user from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and end user from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and end user from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, In - Vitro ADME Services introduction, etc. In - Vitro ADME Services Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of In - Vitro ADME Services
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal In - Vitro ADME Services Market
Global In - Vitro ADME Services market is expected to reach to US$ 952 million in 2023, with a positive growth of %, compared with US$ 870.2 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, In - Vitro ADME Services industry is evaluated to reach US$ 1543.7 million in 2033. The CAGR will be 8.4% during 2023 to 2033.
Global In - Vitro ADME Services companies include Charles River, Labcorp, Envigo, Curia and Evotec. Global top 3 companies hold a share over 32%. North America is the largest market, with a share about 47%, followed by Europe and Asia-Pacific. In terms of product type, Small Molecules is the largest segment, with a share about 80%. In terms of end user, the largest user is Biopharmaceutical Companies, with a share about 80%, followed by Government and Academic Institutes.
Report Covers
This report presents an overview of global In - Vitro ADME Services market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global In - Vitro ADME Services market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, End User and Regions Listed in the Report
By Company
Charles River
Labcorp
Envigo
Curia
Evotec
Bioduro-Sundia
Lonza
WuXi AppTec
IQVIA
Tecan Group
Pharmaron
Shanghai Medicilon
ChemPartner
Joinn Laboratories
RTI International
Eurofins Scientific
Aragen Life Sciences
Sai Life Sciences
Segment by Type
Small Molecules
Biologics
Segment by End User
Biopharmaceutical Companies
Government and Academic Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and end user introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by end user from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and end user from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and end user from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and end user from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and end user from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and end user from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, In - Vitro ADME Services introduction, etc. In - Vitro ADME Services Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of In - Vitro ADME Services
Chapter 13Methodology and Data Sources adopted by MRAResearch